Results for tag: "Lipid Disorder Drug"

The Lipid Disorder Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. These drugs are used to treat conditions such as hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia. Lipid Disorder Drugs are typically administered orally and can be used to reduce the risk of cardiovascular disease. They work by reducing the amount of cholesterol and triglycerides in the blood, as well as increasing the amount of HDL cholesterol. Commonly prescribed drugs include statins, fibrates, and niacin. The Lipid Disorder Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Sanofi, AstraZeneca, and Novartis. Other companies include Bristol-Myers Squibb, GlaxoSmithKline, and Eli Lilly. Show Less Read more